• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proton MR spectroscopy and the detection of malignancy in ovarian masses.质子磁共振波谱与卵巢肿块恶性肿瘤的检测
Br J Radiol. 2019 Sep;92(1101):20190134. doi: 10.1259/bjr.20190134. Epub 2019 Jul 18.
2
Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study.质子磁共振波谱在交界性与恶性上皮性卵巢肿瘤鉴别诊断中的作用:一项初步研究。
J Magn Reson Imaging. 2019 Jun;49(6):1684-1693. doi: 10.1002/jmri.26541. Epub 2018 Oct 24.
3
MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors.磁共振波谱分析鉴别良恶性附件区实性肿瘤。
AJR Am J Roentgenol. 2015 Jun;204(6):W724-30. doi: 10.2214/AJR.14.13391.
4
Improved Diagnostic Accuracy in Characterization of Adnexal Masses by Detection of Choline Peak Using 1H MR Spectroscopy in Comparison to Internal Reference at 3 Tesla.
Asian Pac J Cancer Prev. 2015;16(12):5085-8. doi: 10.7314/apjcp.2015.16.12.5085.
5
Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy.通过多体素质子磁共振波谱对肌肉骨骼肿瘤进行特征描述。
Skeletal Radiol. 2017 Apr;46(4):483-495. doi: 10.1007/s00256-017-2573-1. Epub 2017 Feb 11.
6
Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology.前瞻性验证“卵巢新月征”作为单一超声参数,用于区分良、恶性附件病变。
Ultrasound Obstet Gynecol. 2010 Jul;36(1):81-7. doi: 10.1002/uog.7625.
7
Performance of O-RADS MRI Score in Differentiating Benign From Malignant Ovarian Teratomas: MR Feature Analysis for Differentiating O-RADS 4 From O-RADS 2.O-RADS MRI 评分在鉴别卵巢成熟性畸胎瘤良恶性中的应用:MR 特征分析有助于鉴别 O-RADS 4 类与 O-RADS 2 类。
J Comput Assist Tomogr. 2024;48(5):749-758. doi: 10.1097/RCT.0000000000001629. Epub 2024 Jul 5.
8
Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.骨肿瘤的单体素 1H MR 波谱研究:良性与恶性肿瘤的鉴别。
Eur J Radiol. 2013 Dec;82(12):2124-8. doi: 10.1016/j.ejrad.2011.11.033. Epub 2011 Dec 12.
9
Preliminary observations and clinical value of N-acetyl resonances in ovarian tumours using in-vivo proton MR spectroscopy at 3T.3T 体内质子磁共振波谱对卵巢肿瘤 N-乙酰基共振的初步观察及临床价值
Eur Radiol. 2011 Dec;21(12):2640-6. doi: 10.1007/s00330-011-2215-2. Epub 2011 Aug 5.
10
Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?卵巢不确定肿瘤的半定量对比增强磁共振分析:何时判定为恶性?
Br J Radiol. 2015 Sep;88(1053):20150099. doi: 10.1259/bjr.20150099. Epub 2015 Jun 17.

引用本文的文献

1
Study on the Intervention Mechanism of Cryptotanshinone on Human A2780 Ovarian Cancer Cell Line Using GC-MS-Based Cellular Metabolomics.基于气相色谱-质谱联用的细胞代谢组学研究隐丹参酮对人A2780卵巢癌细胞系的干预机制
Pharmaceuticals (Basel). 2023 Jun 9;16(6):861. doi: 10.3390/ph16060861.
2
Clinical utility of MR spectroscopy for gynecological pelvic abscesses using next-generation sequencing technology for the detection of causative bacteria.使用下一代测序技术检测致病细菌的磁共振波谱在妇科盆腔脓肿中的临床应用
Exp Ther Med. 2023 Jan 12;25(2):96. doi: 10.3892/etm.2023.11796. eCollection 2023 Feb.
3
In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy.利用质子磁共振波谱技术在紫杉醇耐药卵巢癌患者体内检测胆碱代谢失调。
J Transl Med. 2022 Feb 15;20(1):92. doi: 10.1186/s12967-022-03292-z.
4
Magnetic Resonance Spectroscopy for Risk Stratification of Sonographically Indeterminate Ovarian Neoplasms: Preliminary Study.磁共振波谱用于超声检查结果不确定的卵巢肿瘤风险分层的初步研究。
Diagnostics (Basel). 2021 Oct 6;11(10):1847. doi: 10.3390/diagnostics11101847.
5
The use of hyperpolarised C-MRI in clinical body imaging to probe cancer metabolism.超极化碳磁共振成像在临床人体成像中用于探测癌症代谢。
Br J Cancer. 2021 Mar;124(7):1187-1198. doi: 10.1038/s41416-020-01224-6. Epub 2021 Jan 28.

本文引用的文献

1
Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study.质子磁共振波谱在交界性与恶性上皮性卵巢肿瘤鉴别诊断中的作用:一项初步研究。
J Magn Reson Imaging. 2019 Jun;49(6):1684-1693. doi: 10.1002/jmri.26541. Epub 2018 Oct 24.
2
Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?卵巢不确定肿瘤的半定量对比增强磁共振分析:何时判定为恶性?
Br J Radiol. 2015 Sep;88(1053):20150099. doi: 10.1259/bjr.20150099. Epub 2015 Jun 17.
3
MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors.磁共振波谱分析鉴别良恶性附件区实性肿瘤。
AJR Am J Roentgenol. 2015 Jun;204(6):W724-30. doi: 10.2214/AJR.14.13391.
4
MRI for the diagnosis of ultrasonographically indeterminate pelvic masses.
J Pak Med Assoc. 2014 Feb;64(2):171-4.
5
Multimodality imaging of ovarian cystic lesions: Review with an imaging based algorithmic approach.卵巢囊性病变的多模态成像:基于成像的算法方法综述
World J Radiol. 2013 Mar 28;5(3):113-25. doi: 10.4329/wjr.v5.i3.113.
6
New MR techniques in gynecologic cancer.妇科癌症的新磁共振技术。
AJR Am J Roentgenol. 2013 Feb;200(2):249-60. doi: 10.2214/AJR.12.8932.
7
Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients.卵巢癌患者肿瘤特征的体外 1H 和 31P 磁共振波谱分析。
Oncol Rep. 2013 Jan;29(1):321-8. doi: 10.3892/or.2012.2071. Epub 2012 Oct 5.
8
Preliminary observations and clinical value of N-acetyl resonances in ovarian tumours using in-vivo proton MR spectroscopy at 3T.3T 体内质子磁共振波谱对卵巢肿瘤 N-乙酰基共振的初步观察及临床价值
Eur Radiol. 2011 Dec;21(12):2640-6. doi: 10.1007/s00330-011-2215-2. Epub 2011 Aug 5.
9
In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy.利用 3D 磁共振波谱技术在体检测卵巢肿瘤中的胆碱。
Invest Radiol. 2011 Jun;46(6):377-82. doi: 10.1097/RLI.0b013e31821690ef.
10
Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging.附件包块的特征化描述:常规磁共振成像加灌注和弥散加权成像的价值。
Radiology. 2011 Mar;258(3):793-803. doi: 10.1148/radiol.10100751. Epub 2010 Dec 30.

质子磁共振波谱与卵巢肿块恶性肿瘤的检测

Proton MR spectroscopy and the detection of malignancy in ovarian masses.

作者信息

Mansour Sahar Mahmoud, Gomma Mohammed Mohammed Mohammed, Shafik Peter Nashaat

机构信息

1Department of Radiology (Women's imaging unit), Kasr ElAiny Hospital - Faculty of Medicine - Cairo University, Cairo, Egypt.

2Department of Radiology, National Cancer Institute- Faculty of Medicine - Cairo University, Cairo, Egypt.

出版信息

Br J Radiol. 2019 Sep;92(1101):20190134. doi: 10.1259/bjr.20190134. Epub 2019 Jul 18.

DOI:10.1259/bjr.20190134
PMID:31287729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6732908/
Abstract

OBJECTIVE

To assess the impact of MR spectroscopy (MRS) on the detection of malignancy in ovarian masses.

METHODS

This prospective work included 230 females that had 245 adnexal/ovarian masses. Tumours were spotted by preliminary pelvic ultrasound. Masses assessed by MRI, multi- or single-voxel spectroscopy. Patients' spectra were assessed for peaks of lactate (Lac, 1.31 ppm), lipid (Lip, 1.33 ppm), N-acetyl aspartate (2.0 ppm), acetone (A, 2.05 ppm), choline (Cho, 3.23 ppm) and creatinine (Cr, 3.4 ppm) and the mean values of the (Cho/Cr) ratios were performed by a semi-quantitative approach. The operative pathology served as the standard of reference.

RESULTS

Cho peak twofold higher than the average noise level was detected in 72% of the malignant and only 5.4% of the benign masses with an accuracy of 83%. Adding lactate to the choline enhanced the accuracy to 93%. The mean Cho/Cr ratios of the malignant ovarian masses (2.8) were significantly higher than that of the benign ones (1.2) . We used a receiver operating characteristic curve to determine the best cut-off value (1.7) for the mean Cho/Cr ratio to discriminate malignancy with sensitivity: 81.2%, specificity: 93.3 %, positive-predictive value: 92.9 %, negative-predictive value: 82.4% and accuracy: 87.1%.

CONCLUSION

The simultaneous presence of choline and lactate peaks in MRS examination of the ovarian masses minimizes the overlap between benign and malignant categories. N-acetyl aspartate and acetone are the metabolites for diagnosing complex cystic masses as benign teratoma, endomterioma and tubo- ovarian abscess.

ADVANCES IN KNOWLEDGE

MRS is a non-contrast based and fast MR sequence that gives an idea about tissue components could be used to improve the sensitivity and the accuracy of detecting malignancy in ovarian masses.

摘要

目的

评估磁共振波谱(MRS)对卵巢肿块恶性病变检测的影响。

方法

这项前瞻性研究纳入了230名患有245个附件/卵巢肿块的女性。通过初步盆腔超声发现肿瘤。对肿块进行MRI、多体素或单体素波谱分析。评估患者波谱中乳酸(Lac,1.31 ppm)、脂质(Lip,1.33 ppm)、N-乙酰天门冬氨酸(2.0 ppm)、丙酮(A,2.05 ppm)、胆碱(Cho,3.23 ppm)和肌酐(Cr,3.4 ppm)的峰值,并采用半定量方法计算(Cho/Cr)比值的平均值。手术病理作为参考标准。

结果

在72%的恶性肿块和仅5.4%的良性肿块中检测到Cho峰值高于平均噪声水平两倍,准确率为83%。将乳酸与胆碱结合可将准确率提高到93%。恶性卵巢肿块的平均Cho/Cr比值(2.8)显著高于良性肿块(1.2)。我们使用受试者工作特征曲线确定平均Cho/Cr比值的最佳截断值(1.7)以鉴别恶性病变,敏感性为81.2%,特异性为93.3%,阳性预测值为92.9%,阴性预测值为82.4%,准确率为87.1%。

结论

在卵巢肿块的MRS检查中,胆碱和乳酸峰值同时出现可使良性和恶性类别之间的重叠最小化。N-乙酰天门冬氨酸和丙酮是诊断复杂囊性肿块为良性畸胎瘤、子宫内膜瘤和输卵管卵巢脓肿的代谢物。

知识进展

MRS是一种基于非对比剂的快速MR序列,可提供有关组织成分的信息,可用于提高卵巢肿块恶性病变检测的敏感性和准确性。